tm
Seeing Is Believing
tm
Seeing Is Believing
MBRX is currently covered by 3 analysts with an average price target of $6.74. This is a potential upside of $5.47 (430.71%) from yesterday's end of day stock price of $1.27.
Moleculin Biotech's activity chart (see below) currently has 6 price targets and 9 ratings on display. The stock rating distribution of MBRX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 35.42% with an average time for these price targets to be met of 153.25 days.
Highest price target for MBRX is $8, Lowest price target is $8, average price target is $6.74.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 12-Nov-2024. First documented stock forecast 17-Oct-2019.
Currently out of the existing stock ratings of MBRX, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$8
$6.72 (525.00%)
$3
3 months 15 days ago
(12-Nov-2024)
2/3 (66.67%)
$5.36 (203.03%)
463
Buy
$16
$14.72 (1150.00%)
$29
1 years 10 months 9 days ago
(18-Apr-2023)
3/4 (75%)
$3.14 (24.42%)
150
Buy
$5
$4.57 (1062.79%)
1 years 11 months 3 days ago
(24-Mar-2023)
0/1 (0%)
$3.99 (395.05%)
Buy
$18
2 years 7 months 9 days ago
(18-Jul-2022)
0/2 (0%)
$9.38 (181.67%)
What is MBRX (Moleculin Biotech) average time for price targets to be met?
Which analyst has the current highest performing score on MBRX (Moleculin Biotech) with a proven track record?
Which analyst has the current lower performing score on MBRX (Moleculin Biotech) with a proven track record?
Which analyst has the most public recommendations on MBRX (Moleculin Biotech)?
Which analyst is the currently most bullish on MBRX (Moleculin Biotech)?
Which analyst is the currently most reserved on MBRX (Moleculin Biotech)?
